201 related articles for article (PubMed ID: 36895635)
1. Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.
Kantipudi S; Harder D; Fotiadis D
Front Physiol; 2023; 14():1148055. PubMed ID: 36895635
[TBL] [Abstract][Full Text] [Related]
2. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
Kantipudi S; Fotiadis D
Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
[TBL] [Abstract][Full Text] [Related]
3.
Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
[TBL] [Abstract][Full Text] [Related]
4. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
5. Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993041
[TBL] [Abstract][Full Text] [Related]
6. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
Kahlhofer J; Teis D
Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
8. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
[TBL] [Abstract][Full Text] [Related]
9. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
[TBL] [Abstract][Full Text] [Related]
10. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
11. The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1.
Wagner CA; Bröer A; Albers A; Gamper N; Lang F; Bröer S
J Physiol; 2000 Jul; 526 Pt 1(Pt 1):35-46. PubMed ID: 10878097
[TBL] [Abstract][Full Text] [Related]
12. Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation.
Nii T; Segawa H; Taketani Y; Tani Y; Ohkido M; Kishida S; Ito M; Endou H; Kanai Y; Takeda E; Miyamoto Ki
Biochem J; 2001 Sep; 358(Pt 3):693-704. PubMed ID: 11535130
[TBL] [Abstract][Full Text] [Related]
13. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
14. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
16. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.
Wu D; Yan R; Song S; Swansiger AK; Li Y; Prell JS; Zhou Q; Robinson CV
Nat Commun; 2024 May; 15(1):3711. PubMed ID: 38697966
[TBL] [Abstract][Full Text] [Related]
17. Function and structure of heterodimeric amino acid transporters.
Wagner CA; Lang F; Bröer S
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1077-93. PubMed ID: 11546643
[TBL] [Abstract][Full Text] [Related]
18. Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestines.
Ohno C; Nakanishi Y; Honma T; Henmi A; Sugitani M; Kanai Y; Nemoto N
Acta Histochem Cytochem; 2009 Jun; 42(3):73-81. PubMed ID: 19617954
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
Yan R; Li Y; Müller J; Zhang Y; Singer S; Xia L; Zhong X; Gertsch J; Altmann KH; Zhou Q
Cell Discov; 2021 Mar; 7(1):16. PubMed ID: 33758168
[TBL] [Abstract][Full Text] [Related]
20. Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance.
Kanai Y; Endou H
Curr Drug Metab; 2001 Dec; 2(4):339-54. PubMed ID: 11766986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
